4.7 Article

A novel assay reveals preferential binding between Rabs, kinesins, and specific endosomal subpopulations

Journal

JOURNAL OF CELL BIOLOGY
Volume 208, Issue 3, Pages 273-281

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201408056

Keywords

-

Categories

Funding

  1. National Institutes of Health [MH066179]
  2. McDonald Fellowship from the Multiple Sclerosis International Federation

Ask authors/readers for more resources

Identifying the proteins that regulate vesicle trafficking is a fundamental problem in cell biology. In this paper, we introduce a new assay that involves the expression of an FKBP12-rapamycin-binding domain-tagged candidate vesicle-binding protein, which can be inducibly linked to dynein or kinesin. Vesicles can be labeled by any convenient method. If the candidate protein binds the labeled vesicles, addition of the linker drug results in a predictable, highly distinctive change in vesicle localization. This assay generates robust and easily interpretable results that provide direct experimental evidence of binding between a candidate protein and the vesicle population of interest. We used this approach to compare the binding of Kinesin-3 family members with different endosomal populations. We found that KIF1 3A and KIF1 3B bind preferentially to early endosomes and that KIF1A and KIF1 B beta bind preferentially to late endosomes and lysosomes. This assay may have broad utility for identifying the trafficking proteins that bind to different vesicle populations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available